Posimir
NDC Package 51715-660-10
Package Information
Posimir is indicated in adults for administration into the subacromial space under direct arthroscopic visualization to produce post-surgical analgesia for up to 72 hours following arthroscopic subacromial decompression. Marketed by Innocoll Pharmaceuticals, this product is identified by NDC 51715-660 and is authorized under FDA application NDA204803.
Identification & Billing
- RxCUI: 2563412 - BUPivacaine 660 MG in 5 mL Injection
- RxCUI: 2563412 - 5 ML bupivacaine 132 MG/ML Injection
- RxCUI: 2563412 - bupivacaine 660 MG per 5 ML Injection
- RxCUI: 2563417 - Posimir 660 MG in 5 mL Injection
- RxCUI: 2563417 - 5 ML bupivacaine 132 MG/ML Injection [Posimir]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51715 - Innocoll Pharmaceuticals
- 51715-660 - Posimir
- 51715-660-10 - 10 VIAL in 1 CARTON / 5 mL in 1 VIAL
- 51715-660 - Posimir
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51715-660-10 identifies a specific commercial package of 10 vial in 1 carton / 5 ml in 1 vial of Posimir, labeled by Innocoll Pharmaceuticals. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Innocoll Pharmaceuticals on May 31, 2022. The current certification is valid through December 31, 2023.
How is this Innocoll Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51715066010. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.